• Price (USD)24.83
  • Today's Change-0.16 / -0.64%
  • Shares traded500.86k
  • 1 Year change+4.33%
  • Beta1.3609
Data delayed at least 15 minutes, as of Aug 16 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ADTRAN Holdings, Inc. is a provider of networking and communications platforms, software, and services focused on the broadband access market. The Company operates through two segments: Network Solutions segment, which includes hardware and software products, and Services & Support segment consists of a portfolio of maintenance, network installation and solution integration services, which include hosted cloud services and subscription services. The two segments span across Access & Aggregation, Subscriber Solutions & Experience and Traditional & Other Products. Its Access & Aggregation is focused on solutions that are used by service providers to connect their network infrastructure to subscribers. Its Subscriber Solutions & Experience is concentrated on subscriber solutions that terminate broadband access in the home and/or business. It also develops and provides networking solutions to network operators focusing on cloud access, cloud interconnection and network synchronization.

  • Revenue in USD (TTM)618.80m
  • Net income in USD-13.60m
  • Incorporated2021
  • Employees1.34k
  • Location
    ADTRAN Holdings Inc901 Explorer BlvdHUNTSVILLE 35806United StatesUSA
  • Phone+1 (256) 963-8220
  • Fax+1 (302) 655-5049
  • Websitehttps://acorn-offer.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ADTN:NSQ since
ADVA Optical Networking SEDeal completed30 Aug 202130 Aug 2021Deal completed1.06%1.03bn
Data delayed at least 15 minutes, as of Aug 16 2022 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Agios Pharmaceuticals Inc6.41m-369.42m1.50bn390.00--1.38--241.19-6.71-6.710.116320.510.0041--1.0316,446.15-23.63-38.82-24.48-43.4287.93---5,759.64-1,199.3817.89--0.0011-------8.26---10.35--
Sana Biotechnology Inc0.00-297.91m1.51bn461.00--2.41-----1.61-1.610.003.390.00----0.00-26.71---28.49--------------0.00-------24.75------
Recursion Pharmaceuticals Inc12.95m-211.74m1.52bn400.00--3.42--131.11-1.31-1.310.082.890.0257--246.6532,372.50-42.08---47.39---19.04---1,635.19-----81.010.0014--156.89---114.33------
Pra Group Inc1.02bn145.21m1.53bn3.44k11.251.279.431.503.423.4223.9330.450.2442--0.3121295,850.603.523.133.703.2879.9982.6714.4012.89--2.550.67630.002.853.3222.6516.25-4.56--
Verve Therapeutics Inc0.00-125.20m1.62bn113.00--5.25-----2.58-2.580.006.080.00----0.00-33.35---34.96--------------0.00-------163.25------
Monro Inc1.37bn57.88m1.65bn8.75k30.282.2211.941.211.701.7040.1723.220.73756.00100.25156,233.703.153.823.874.5134.9737.144.274.980.32094.330.389550.6620.755.8880.330.0066-4.288.23
Day One Biopharmaceuticals Inc0.00-105.46m1.67bn94.00--4.43-----1.77-1.770.005.320.00----0.00-29.27---30.00--------------0.00-------321.26------
Taskus Inc913.95m50.05m1.73bn40.10k35.363.8916.271.850.48880.48888.834.441.07--5.9322,791.755.84--8.01--42.59--5.48----11.050.3797--59.13---269.98------
Stagwell Inc-100.00bn-100.00bn1.79bn9.10k--5.37----------1.16-----------1.29---2.61--34.22---1.72----0.6037--22.551.1898.48---5.12--
Adtran Holdings Inc618.80m-13.60m1.83bn1.34k--3.421,183.013.03-0.2801-0.280112.607.101.072.534.18463,516.80-2.36-1.57-3.26-1.9435.3841.62-2.20-1.681.16-1.04----11.15-2.43-463.12---23.360.00
Alvotech SA-100.00bn-100.00bn1.83bn805.00-------------------------------------------------42.86--40.31------
Lyell Immunopharma Inc41.87m-237.05m1.86bn219.00--2.17--45.16-0.9631-0.96310.17063.510.0372----191,191.80-21.06---22.18-------566.14------0.00--37.31---22.37------
ICF International Inc1.62bn68.73m1.89bn8.00k27.902.3118.061.173.613.6184.8643.540.9293--4.04210,210.803.954.404.955.6936.5036.194.254.25--11.160.354513.993.065.5629.438.837.64--
Prometheus Biosciences Inc6.29m-108.32m1.95bn72.00--9.36--308.57-2.78-2.780.16165.290.0219--5.5687,333.34-37.77---39.57-------1,722.58-----1,297.340.00--154.60---189.65------
Frontdoor Inc1.65bn117.00m2.02bn2.08k18.53347.6813.821.271.381.3819.680.07361.49--122.07791,926.9010.5810.4916.9216.6545.4548.357.109.61--6.930.99040.008.689.4514.290.63723.03--
Xpel Inc294.42m34.24m2.08bn709.0065.3121.7054.727.601.241.2410.663.732.003.7018.55415,253.9023.2625.6829.9035.2237.3133.1311.6310.140.826927.750.2378--63.1438.0272.6770.1241.35--
Data as of Aug 16 2022. Currency figures normalised to ADTRAN Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

57.37%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20227.29m14.78%
The Vanguard Group, Inc.as of 30 Jun 20225.13m10.40%
DNB Asset Management ASas of 15 Jul 20222.47m5.01%
Newton Investment Management North America LLCas of 31 Mar 20222.43m4.92%
Dimensional Fund Advisors LPas of 30 Jun 20222.25m4.56%
Westwood Management Corp. (Texas)as of 31 Mar 20222.24m4.55%
Fuller & Thaler Asset Management, Inc.as of 30 Jun 20222.01m4.07%
SSgA Funds Management, Inc.as of 31 Mar 20221.64m3.33%
Bernzott Capital Advisorsas of 30 Jun 20221.61m3.26%
Schonfeld Strategic Advisors LLCas of 31 Mar 20221.24m2.51%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.